MRP Capital Investments »

Zenas Biopharma shares owned by MRP Capital Investments

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by MRP Capital Investments from 13F filings

Historical chart of MRP Capital Investments investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by MRP Capital Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by MRP Capital Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $593 35 16.94

More positions owned by MRP Capital Investments

Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Fortinet (FTNT)
Wal-Mart Stores (WMT)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Dell Technologies CL C (DELL)
Palo Alto Networks (PANW)

View all positions for MRP Capital Investments

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma